The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical evidence.
- DOI
- 10.3389/fcvm.2026.1726611
- Published
- 2026
- Container
- Frontiers in cardiovascular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcvm.2026.1726611,
title = {The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical evidence.},
author = {Zhang Y and Xiao X and Yan Q and Huang D and Wang W},
year = {2026},
journal = {Frontiers in cardiovascular medicine},
doi = {10.3389/fcvm.2026.1726611},
url = {https://doi.org/10.3389/fcvm.2026.1726611}
}RIS
TY - JOUR TI - The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical evidence. AU - Zhang Y AU - Xiao X AU - Yan Q AU - Huang D AU - Wang W PY - 2026 JO - Frontiers in cardiovascular medicine DO - 10.3389/fcvm.2026.1726611 UR - https://doi.org/10.3389/fcvm.2026.1726611 ER -
APA
Y, Z., X, X., Q, Y., D, H., & W, W. (2026). The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical evidence.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1726611
Source records
- pubmed · retrieved 2026-09-26T19:11:15.412Z